Posterior reversible encephalopathy syndrome secondary to blood transfusion

Rissardo, Jamir Pitton; Caprara, AnaLetícia Fornari

doi:10.4103/ljms.ljms_62_21

Cited by 1 publication

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Posterior reversible encephalopathy syndrome (PRES) is a neurological disorder characterized by a variety of symptoms, including headaches, seizures, altered mental status, and visual disturbances [157]. PRES is often associated with reversible brain vasogenic edema (fluid accumulation), particularly in the posterior regions of the brain [158].…”

Section: Posterior Reversible Encephalopathy Syndromementioning

confidence: 99%

“…While movement disorders are not typically observed in PRES, it's essential to recognize that the syndrome can have a wide range of neurological symptoms, and the specific manifestations can vary among individuals [159]. The primary focus in managing PRES is identifying and addressing the underlying cause or triggers and providing supportive care to manage symptoms [158].…”

Section: Posterior Reversible Encephalopathy Syndromementioning

confidence: 99%

See 1 more Smart Citation

A Literature Review of Movement Disorder Associated with Medications and Systemic Diseases

Pitton Rissardo,

Fornari Caprara

2024

Preprint

View full text Add to dashboard Cite

Movement disorders can be associated with various drugs and systemic diseases, posing diagnostic challenges for clinicians. This review explores the spectrum of movement disorders associated with pharmacological agents and medical conditions. Drug-induced movement disorders encompass a broad range of conditions resulting from exposure to medications that affect several neurotransmitters. Neuroleptic medications can lead to tardive dyskinesia, characterized by involuntary, repetitive movements. Antipsychotics and antiemetics, including metoclopramide, may induce acute dystonic reactions. Other drugs, such as dopamine receptor-blocking agents, can contribute to drug-induced parkinsonism. Beyond medications, movement disorders can also arise secondary to systemic diseases. Metabolic disorders like Wilson's disease, characterized by copper accumulation, may manifest as chorea or dystonia. Inflammatory conditions such as rheumatoid arthritis and systemic lupus erythematosus can result in secondary movement disorders due to autoimmune-mediated processes affecting the central nervous system. Movement disorders linked to drugs or systemic diseases often necessitate a thorough clinical evaluation, including detailed medication histories and comprehensive systemic assessments. Neuroimaging, laboratory investigations, and, in some cases, cerebrospinal fluid analyses and electrodiagnostic studies help in establishing accurate diagnoses. Management involves addressing the underlying cause, modifying medications, and employing symptomatic treatments.

show abstract

Section: Posterior Reversible Encephalopathy Syndromementioning

confidence: 99%

Section: Posterior Reversible Encephalopathy Syndromementioning

confidence: 99%